332
In this case report, we have described a patient with Crohn's disease who developed subfulminant hepatitis B after the fourth infusion of infliximab due to an unrecognized HBs-antigen carrier state.
 a patient with Crohn's disease: Subject; subfulminant hepatitis B: Effect; fourth infusion of infliximab: Treatment; Crohn's disease: Treatment.Disorder; fourth: Treatment.Time_elapsed; infliximab: Treatment.Drug; infusion: Treatment.Route
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a patient with Crohn's disease: Subject; subfulminant hepatitis B: Effect; fourth infusion of infliximab: Treatment; Crohn's disease: Treatment.Disorder; fourth: Treatment.Time_elapsed; infliximab: Treatment.Drug; infusion: Treatment.Route